1st-line treatment of patients w/ locally advanced or metastatic non-small cell lung cancer stage IIIb/IV w/ EGFR activating mutations; after failure at least 1 prior chemotherapy regimen. In combination w/ gemcitabine in patients w/ locally advanced unresectable or metastatic pancreatic cancer.
Dosage/Direction for Use
Non-small cell lung cancer 150 mg daily. Pancreatic cancer 100 mg daily in combination w/ gemcitabine.
Administration
Should be taken on an empty stomach: Take at least 1 hr before or 2 hr after meals.
Sign Out
